MX9305933A - Metodo para antagonizar al 1,4,5-trifosfato de inositol. - Google Patents

Metodo para antagonizar al 1,4,5-trifosfato de inositol.

Info

Publication number
MX9305933A
MX9305933A MX9305933A MX9305933A MX9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A
Authority
MX
Mexico
Prior art keywords
inositol
triphosphate
antagonize
oligometers
formula
Prior art date
Application number
MX9305933A
Other languages
English (en)
Spanish (es)
Inventor
Kenneth A Stauderman
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of MX9305933A publication Critical patent/MX9305933A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9305933A 1992-09-28 1993-09-27 Metodo para antagonizar al 1,4,5-trifosfato de inositol. MX9305933A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95239392A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
MX9305933A true MX9305933A (es) 1994-04-29

Family

ID=25492868

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305933A MX9305933A (es) 1992-09-28 1993-09-27 Metodo para antagonizar al 1,4,5-trifosfato de inositol.

Country Status (13)

Country Link
EP (1) EP0661982A1 (enExample)
JP (1) JPH08502068A (enExample)
KR (1) KR950703347A (enExample)
AU (1) AU670962B2 (enExample)
CA (1) CA2145681A1 (enExample)
HU (1) HUT70192A (enExample)
IL (1) IL107066A (enExample)
MX (1) MX9305933A (enExample)
NO (1) NO951163D0 (enExample)
NZ (1) NZ256178A (enExample)
TW (1) TW260663B (enExample)
WO (1) WO1994007507A1 (enExample)
ZA (1) ZA936978B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2978995A (en) * 1994-06-30 1996-01-25 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Methods for treating cell proliferative disorders by modulating signal transduction
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
KR20000022274A (ko) * 1996-06-27 2000-04-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 Il-8 수용체 길항제
TR199802695T2 (xx) 1996-06-27 1999-04-21 Smithkline Beecham Corporation IL-8 Resept�r kar��tlar�
AU2002214886A1 (en) * 2000-11-09 2002-05-21 Contrimmune Biotechnology Inc Therapeutic uses for IP3 receptor-mediated calcium channel modulators
MX2014002535A (es) 2011-09-02 2015-07-17 Univ Columbia Inhibidores de camkii, ip3r, calcineurina, p38 y mk2/3 para tratar las alteraciones metabolicas de la obesidad.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
HUT70192A (en) 1995-09-28
HU9500891D0 (en) 1995-05-29
AU4841793A (en) 1994-04-26
AU670962B2 (en) 1996-08-08
KR950703347A (ko) 1995-09-20
IL107066A (en) 1998-01-04
IL107066A0 (en) 1993-12-28
CA2145681A1 (en) 1994-04-14
WO1994007507A1 (en) 1994-04-14
ZA936978B (en) 1994-04-18
NZ256178A (en) 1997-03-24
NO951163L (no) 1995-03-27
JPH08502068A (ja) 1996-03-05
NO951163D0 (no) 1995-03-27
EP0661982A1 (en) 1995-07-12
TW260663B (enExample) 1995-10-21

Similar Documents

Publication Publication Date Title
DE69324859D1 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
MX9305933A (es) Metodo para antagonizar al 1,4,5-trifosfato de inositol.
ATE206919T1 (de) Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen
CU23393A3 (es) Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen
BR0116001A (pt) Métodos para tratar distúrbios neuropsiquiátricos com antagonistas receptores nmda
ES2108120T3 (es) Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf.
ES2135083T3 (es) Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis.
ES2120993T3 (es) Agentes antitromboticos.
DE69022953D1 (de) Zusammensetzungen zur Behandlung von Fettablagerungen.
ES2116436T3 (es) Carbamatos y agentes protectores de las plantas que les contienen.
PT729468E (pt) Antagonistas nao peptidicos de receptores de taquiquininas
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
PT841928E (pt) Formulacao de libertacao prolongada de d-trep-metilfenidato
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
DE3867736D1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
GB2223169B (en) Inositol trisphosphate for the treatment of bone disorders
MX9401175A (es) Inhibidores de la acetilcolinesterasa sililada.
MX9301298A (es) Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BR8902892A (pt) Processo para a preparacao de hidrazinas substituidas e composicao inseticida
DE69432124D1 (de) Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
SE9404568D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
MX9305914A (es) 2-arilpirroles, procedimiento para su preparacion y agentes pesticidas quelos contienen.
MX166685B (es) Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas